HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian U Pfister Selected Research

selurampanel

1/2021Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian U Pfister Research Topics

Disease

1Dizziness (Lightheadedness)
01/2021
1Tinnitus
01/2021

Drug/Important Bio-Agent (IBA)

1selurampanelIBA
01/2021
1AMPA Receptors (AMPA Receptor)IBA
01/2021
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2021
1Excitatory Amino Acid AntagonistsIBA
01/2021